MyFinsight
Home
Blog
About
Back
Income Statement
Karyopharm Therapeutics Inc. (KPTI)
Karyopharm Therapeutics Inc. (KPTI)
source: myfinsight.com
Net loss
-$67,023K
(-79.92%↓ Y/Y)
Gross product revenue
$41,944K
Loss before income
taxes
-$67,023K
(-80.11%↓ Y/Y)
Product
$30,776K
License And Other
$2,656K
Provisions for product
revenue
$11,168K
Total other expense,
net
-$44,497K
(-246.96%↓ Y/Y)
Loss from operations
-$22,526K
(7.63%↑ Y/Y)
Interest income
$722K
(17.78%↑ Y/Y)
Revenue from contract
with customer,...
$33,432K
(-11.86%↓ Y/Y)
Other (expense)
income, net
-$32,075K
(-1351.36%↓ Y/Y)
Interest expense
$13,144K
(17.06%↑ Y/Y)
Total operating
expenses
$55,958K
(-10.20%↓ Y/Y)
Research and development
$28,957K
(-11.68%↓ Y/Y)
Selling, general and
administrative
$25,916K
(-8.99%↓ Y/Y)
Cost of sales
$1,085K
(3.24%↑ Y/Y)
Back